DecideAct closes contract with first customer in the pharma engineering industry.

DecideAct has today signed a contract with the first customer in the pharmaceutical engineering industry. It is an international leading company in the field with offices in several countries.

DecideAct A/S [ACT]

Company Announcement No. 23-2021:

We are proud to announce that DecideAct now enters a new industry as we have signed the first contract with a company in the pharma engineering field and are welcoming them on board as a DecideAct customer. The new customer is a significant player in the sector globally.

Strategy Execution Expert at DecideAct, Lars Møller states: “We are looking forward to supporting our new client with their strategy execution as our first customer in the pharmaceutical engineering industry. The contract is an important step for us, as this is a customer that is known and well respected throughout the world, and we have good experience in transferring our knowledge from an industry to related markets.”

CEO and Co-founder of DecideAct, Flemming Videriksen, is very pleased with the agreement, which he believes could open new doors for DecideAct. “In my best judgment, this deal will give DecideAct significant traction among other very large companies in the markets we operate in,” Videriksen states.

This press release constitutes inside information that DecideAct A/S is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was sent for publication, through the agency of the contact persons set out below, at the time stated by the Company's news distributor, Cision, at the publication of this press release.